Skip to content

Drug interactions

Darunavir + Regorafenib

Severity: Major

Darunavir and Regorafenib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Darunavir, especially when boosted with ritonavir or cobicistat, strongly inhibits CYP3A4 and may increase regorafenib exposure, with unpredictable changes in active metabolites.

What this interaction means in plain words

Darunavir and Regorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Darunavir belongs to Anti Virals; Regorafenib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition by boosted darunavir reduces regorafenib clearance.

What to do

Avoid the combination if possible. If coadministration is necessary, monitor liver function and for adverse reactions.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darunavir and Regorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Darunavir with Regorafenib?

MediHelp rates the interaction as major. Darunavir and Regorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Darunavir, especially when boosted with ritonavir or cobicistat, strongly inhibits CYP3A4 and may increase regorafenib exposure, with unpredictable changes in active metabolites.

How serious is the interaction between Darunavir and Regorafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If coadministration is necessary, monitor liver function and for adverse reactions.

What other medicines interact with Regorafenib?

MediHelp also lists interactions of Regorafenib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Regorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in